- Home
- WAI vs TOVX Comparison
WAI vs TOVX Comparison
Compare WAI & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAI
- TOVX
- Stock Information
- Founded
- WAI 2018
- TOVX 2001
- Country
- WAI China
- TOVX United States
- Employees
- WAI N/A
- TOVX N/A
- Industry
- WAI
- TOVX Biotechnology: Pharmaceutical Preparations
- Sector
- WAI
- TOVX Health Care
- Exchange
- WAI NYSE
- TOVX Nasdaq
- Market Cap
- WAI 5.5M
- TOVX 4.5M
- IPO Year
- WAI 2023
- TOVX 2006
- Fundamental
- Price
- WAI $0.48
- TOVX $0.50
- Analyst Decision
- WAI
- TOVX Hold
- Analyst Count
- WAI 0
- TOVX 1
- Target Price
- WAI N/A
- TOVX N/A
- AVG Volume (30 Days)
- WAI 5.9M
- TOVX 170.2K
- Earning Date
- WAI 08-24-2025
- TOVX 08-12-2025
- Dividend Yield
- WAI N/A
- TOVX N/A
- EPS Growth
- WAI N/A
- TOVX N/A
- EPS
- WAI N/A
- TOVX N/A
- Revenue
- WAI $3,750,352.00
- TOVX N/A
- Revenue This Year
- WAI N/A
- TOVX N/A
- Revenue Next Year
- WAI N/A
- TOVX N/A
- P/E Ratio
- WAI N/A
- TOVX N/A
- Revenue Growth
- WAI N/A
- TOVX N/A
- 52 Week Low
- WAI $0.41
- TOVX $0.40
- 52 Week High
- WAI $20.00
- TOVX $7.25
- Technical
- Relative Strength Index (RSI)
- WAI N/A
- TOVX 52.75
- Support Level
- WAI N/A
- TOVX $0.45
- Resistance Level
- WAI N/A
- TOVX $0.52
- Average True Range (ATR)
- WAI 0.00
- TOVX 0.03
- MACD
- WAI 0.00
- TOVX 0.01
- Stochastic Oscillator
- WAI 0.00
- TOVX 77.78
About WAI TOP KINGWIN LTD
Top KingWin Ltd operates as a corporate business training and consulting company, providing personal and management training and financial consulting services. It provides some essential business services in China to young and emerging companies, including corporate business training services, which mainly focus on knowledge and new perspectives on the capital markets; corporate consulting services, which mainly focus on various aspects of fundraising; and advisory and transaction services. Its main clients are entrepreneurs and executives in China's small and medium enterprises (SMEs).
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.